Expanded cohort results from CheckMate 016: A phase I study of nivolumab in combination with ipilimumab in metastatic renal cell carcinoma (mRCC).
Year: 2015
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Hans J. Hammers, Elizabeth R. Plimack, Jeffrey R. Infante, Brian I. Rini, David F. McDermott, Marc Ernstoff, Martin Henner Voss, Padmanee Sharma, Sumanta Kumar Pal, Albiruni R. A. Razak, Christian K. Kollmannsberger, Daniel Yick Chin Heng, Jennifer L. Spratlin, Yun Shen, Paul Gagnier, Asim Amin
Institutions: Sidney Kimmel Comprehensive Cancer Center, Fox Chase Cancer Center, Sarah Cannon, Tennessee Oncology, Cleveland Clinic, Beth Israel Deaconess Medical Center, Memorial Sloan Kettering Cancer Center, The University of Texas MD Anderson Cancer Center, City Of Hope National Medical Center, University of Toronto, Princess Margaret Cancer Centre, BC Cancer Agency, University of Calgary, University of Alberta, Cross Cancer Institute, Bristol-Myers Squibb (United States), Levine Cancer Institute
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2590211874